.png){kind=icon}
.png){kind=icon}
Return
Brief Report: An Observational Population Level Study Of Neoadjuvant Chemoimmunotherapy for Resectable Non-Small Cell Lung Cancer
.png){kind=icon}
OA
AI
S
A
M
A
B
V
DOI：10.1016/j.cllc.2026.07.003.png)
.png){kind=icon}
.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
Neoadjuvant chemoimmunotherapy (NCIT) is being increasingly used in the treatment of resectable and early-stage NSCLC based on recent randomized controlled trials. The real-world effectiveness of this approach remains uncertain. We aimed to evaluate pathological response, treatment completion, surgical outcomes and rates of relapse among patients with resectable NSCLC treated with NCIT in routine practice.
AI Summary
Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.
Journal
IF:
3.3
Papers:
2.4K
Citations:
4.5K
Organization
Cited Papers